Professor, Internal Medicine, Mayo Medical School
Gastroenterology
Dr. John J. Poterucha, MD
|
|
Give Review
John Poterucha is an expert in the field of Gastroenterology. John J. Poterucha, MD is also published. He has 71 publications published. The lastest publication: "TT-virus infection in North American blood donors, patients with fulminant hepatic failure, and cryptogenic cirrhosis.' Doctor John J. Poterucha, MD is registered with Medicare.
Publications
- Primary Biliary cirrhosis by another name is still PBC.
- Potential Efficacy of Pegylated Interferon-α and a Nucleos(t)ide Analogue as Combination Therapy for HBeAg-Positive Chronic Hepatitis B.
- IL28B and fibrosing cholestatic Hepatitis in posttransplant Hepatitis C: A case-control study and literature review.
- Ultrasound-based transient elastography for the detection of hepatic fibrosis in patients with recurrent HCV after liver transplantation: Systematic review and meta-an...
- Drug therapy: Telaprevir.
- Treatment of Hepatitis C-Mediated Glomerular Disease.
- Interleukin-28B polymorphisms are associated with histological recurrence and treatment response following liver transplantation in patients with Hepatitis C virus inf...
- Impact of depressive symptoms and their treatment on completing antiviral treatment in patients with chronic Hepatitis C.
- IgG4+ plasma cell infiltrates in liver explants with primary sclerosing cholangitis.
- Use of a small-caliber angioplasty balloon for the management of an impassable choledochocholedochal anastomotic Biliary stricture.
- Histologic abnormalities are common in protocol liver allograft biopsies from patients with normal liver function tests.
- The prevalence and natural history of untreated isolated central perivenulitis in adult allograft livers.
- Endoscopic retrograde cholangiography in post-orthotopic liver transplant population with Roux-en-Y Biliary reconstruction.
- Natural history of Hepatitis B virus infection: an update for clinicians.
- A moveable feast.
- Steatosis in Hepatitis C: the missing link to metabolic abnormalities?
- Insertion and removal of covered expandable metal stents for closure of complex Biliary leaks.
- Hepatitis B immunization after liver transplantation: what is the answer?
- The impact of competing risks on the observed rate of chronic Hepatitis C progression.
- Outcome of liver transplantation for Hepatitis B in the United States.
- Histologic changes mimicking Biliary disease in liver biopsies with venous outflow impairment.
- Recurrence of primary Biliary cirrhosis after liver transplantation: Histologic estimate of incidence and natural history.
- Spontaneous bacterial peritonitis in asymptomatic outpatients with cirrhotic ascites.
- Treatment of posttransplantation recurrence of Hepatitis C with interferon and ribavirin: lessons on tolerability and efficacy.
- Use of cyclosporine with poor initial renal function results in severely diminished renal clearance up to three years following liver transplantation.
- Early identification of recipients with progressive histologic recurrence of Hepatitis C after liver transplantation.
- TT-virus infection in North American blood donors, patients with fulminant hepatic failure, and cryptogenic Cirrhosis.
- Post-liver transplantation myocardial dysfunction.
- Optimal timing of liver transplantation for primary Biliary cirrhosis.
- Treatment of chronic Hepatitis C with interferon with or without ursodeoxycholic acid: a randomized prospective trial.
- Cost-effectiveness of 6 and 12 months of interferon-alpha therapy for chronic Hepatitis C.
- Hepatitis C genotypes in liver transplant recipients: distribution and 1-year follow-up.
- Does antimitochondrial antibody status affect response to treatment in patients with primary Biliary cirrhosis? Outcomes of ursodeoxycholic acid therapy and liver tran...
- Relationship between Hepatitis C genotype and severity of recurrent Hepatitis C after liver transplantation.
- Liver transplantation and Hepatitis B.
- Fulminant Hepatitis B virus: recurrence after liver transplantation in two patients also infected with Hepatitis delta virus.
- Recurrence of nonalcoholic steatoHepatitis following liver transplantation.
- Increased risk of hepatocellular carcinoma in patients infected with Hepatitis C genotype 1b.
- Cost-effective analysis of surgical palliation versus endoscopic stenting in the management of unresectable pancreatic cancer.
- Thoracic duct-cutaneous fistula in a patient with Cirrhosis of the liver: successful treatment with a transjugular intrahepatic portosystemic shunt.
- Granulomas in primary sclerosing cholangitis.
- Advances in liver biopsy diagnosis.
- Failure of hepatopulmonary syndrome to resolve after liver transplantation and successful treatment with embolotherapy.
- Hepatitis C after liver transplantation.
- Epidemiology and natural history of Hepatitis C infections in liver transplant recipients.
- Chronic inflammatory demyelinating polyneuropathy complicating liver transplantation.
- Hepatotoxicity after desflurane anesthesia.
- Human leukocyte antigen DR markers as predictors of progression to liver transplantation in patients with chronic Hepatitis C.
- Adaptation of the Mayo primary Biliary cirrhosis natural history model for application in liver transplant candidates.
- A revised natural history model for primary sclerosing cholangitis.
- Early detection of Hepatitis C allograft reinfection after orthotopic liver transplantation: a molecular and histologic study.
- Cost-effectiveness of interferon alfa 2b and ribavirin in the treatment of chronic Hepatitis C.
- Hepatitis A antibodies in liver transplant recipients: evidence for loss of immunity posttransplantation.
- Endoscopic therapy of anastomotic bile duct strictures occurring after liver transplantation.
- Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis.
- Clinical significance of TT virus infection in patients with chronic Hepatitis C.
- Hepatic retransplantation in cholestatic liver Disease: impact of the interval to retransplantation on survival and resource utilization.
- The relative role of the Child-Pugh classification and the Mayo natural history model in the assessment of survival in patients with primary sclerosing cholangitis.
- The clinical significance of simultaneous infection with Hepatitis G virus in patients with chronic Hepatitis C.
- Recurrence of primary sclerosing cholangitis following liver transplantation.
- Impact of pegylated interferon and ribavirin treatment on graft survival in liver transplant patients with recurrent Hepatitis C infection.
- Is it time for mass screening for Hepatitis C?
- Safety and efficacy of Hepatitis A vaccination in liver transplantation recipients.
- Helicobacter pylori-associated gastric MALT lymphoma in liver transplant recipients.
- Outcome of hospital care of liver Disease associated with hepatitis C in the United States.
- Hepatitis C antibodies in patients with chronic Hepatitis of unknown etiology after orthotopic liver transplantation.
- Diagnosis of chronic Hepatitis C after liver transplantation by the detection of viral sequences with polymerase chain reaction.
- Insulin resistance, serum adipokines and risk of fibrosis progression in patients transplanted for Hepatitis C.
- Noninvasive diagnosis of acute cellular rejection in liver transplant recipients: a proteomic signature validated by enzyme-linked immunosorbent assay.
- Liver involvement in systemic lupus erythematosus: case review of 40 patients.
Schools
Southern Illinois University School Of Medicine
Mayo Grad School MedMayo Fndn
Procedures Preformed
- Colonoscopy, Proctosigmoidoscopy, and Sigmoidoscopy
- Endoscopy (Esophagus, Stomach, Small Intestine)
- ERCP (Endoscopic Retrograde Cholangiopancreatography)
- Liver Biopsy
Conditions Treated
- Abdominal Pain
- Anemia
- Biliary Atresia
- Cholecystitis and Gallstones
- View All
Doctors Specialties
- Gastroenterology
- Transplant Hepatology
Accepted Insurances
Education
-
Mayo School of Graduate Medical Education
Hospital
-
Mayo Clinic - Rochester, Minnesota
Drug Facts
| NPI NUMBER | 1083689475 | |
| NPPES Provider LastName | POTERUCHA | |
| NPPES Provider FirstName | JOHN | |
| NPPES Provider ZIPCode | 559050001 | |
| NPPES Provider State | MN | |
| Specialty Description | Gastroenterology | |
| Total Claim Count | 2229.0 | |
| Distinct Opioid Count | 3.0 | |
| Opioid Claim Count | 49.0 | |
| Percent Opioid Claims | 2.2 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1083689475 |
| Last Name Of The Provider | POTERUCHA |
| First Name Of The Provider | JOHN |
| View All |
Similar Doctors
|
|
Dr. Nadim I. Salfiti, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rosanne M. Danielson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Barrett G. Levesque, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jaime Zighelboim, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michel N. Sultan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Yan G. Bakman, MD |